← Back to Search

Behavioral Intervention

Cognitive Enhancement Therapy for Psychosis and Alcoholism

N/A
Recruiting
Led By Philip G Tibbo, MD
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Less than 5 years of psychotic illness
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will look at how reducing alcohol use can improve the treatment of early phase psychosis in young people. It will measure symptoms, hospitalizations, school/work and relationships to track long-term recovery.

Who is the study for?
This trial is for young people aged 16-35 in Nova Scotia who are in the early stages of a psychotic illness (like schizophrenia) and have issues with drinking too much alcohol, as shown by scoring 8 or higher on a specific WHO test.
What is being tested?
The study tests Cognitive Enhancement Therapy to see if it helps reduce alcohol use among those with early phase psychosis. It will be compared to standard care, which includes just one session about the dangers of alcohol.
What are the potential side effects?
Since this intervention focuses on therapy rather than medication, side effects may include discomfort from discussing personal issues but are not expected to involve physical symptoms typically associated with drug treatments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had a psychotic illness for less than 5 years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Alcohol consumption (mL per day)
Secondary study objectives
Engagement based on gender
Feasibility of a shortened intervention
Possible role of gender in alcohol consumption

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive enhancement therapy (CET)Experimental Treatment1 Intervention
Cognitive enhancement therapy with an aim to reduce alcohol consumption
Group II: Treatment as UsualActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Nova Scotia Health AuthorityLead Sponsor
288 Previous Clinical Trials
94,538 Total Patients Enrolled
2 Trials studying Psychosis
142 Patients Enrolled for Psychosis
Phil TibboLead Sponsor
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,389 Previous Clinical Trials
26,519,420 Total Patients Enrolled
3 Trials studying Psychosis
691 Patients Enrolled for Psychosis
~11 spots leftby Jun 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top